|
NL6815872A
(enExample)
|
1967-11-22 |
1969-05-27 |
|
|
|
JPS5614663B2
(enExample)
*
|
1971-08-21 |
1981-04-06 |
|
|
|
US4582833A
(en)
|
1984-04-16 |
1986-04-15 |
American Cyanamid Company |
2-(substituted-1-piperazinyl)[1,2,4]triazolo[1,5-a]pyrimidines
|
|
JPS6130554A
(ja)
|
1984-07-23 |
1986-02-12 |
Ono Pharmaceut Co Ltd |
プロスタグランジン類似化合物のある特定の立体配置を有する異性体及びそれらを有効成分として含有する治療剤
|
|
US4576943A
(en)
|
1984-10-09 |
1986-03-18 |
American Cyanamid Company |
Pyrazolo[1,5-a]pyrimidines
|
|
DE3608088C2
(de)
|
1986-03-07 |
1995-11-16 |
Schering Ag |
Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
|
|
WO1989000559A1
(fr)
|
1987-07-17 |
1989-01-26 |
Schering Aktiengesellschaft Berlin Und Bergkamen |
Derives de 9-halogene-(z)-prostaglandine, leur procede de production et leur utilisation comme medicaments
|
|
US5308852A
(en)
|
1992-06-29 |
1994-05-03 |
Merck Frosst Canada, Inc. |
Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
|
|
US5631401A
(en)
|
1994-02-09 |
1997-05-20 |
Abbott Laboratories |
Inhibitors of protein farnesyltransferase and squalene synthase
|
|
US5585492A
(en)
*
|
1994-10-11 |
1996-12-17 |
G. D. Searle & Co. |
LTA4 Hydrolase inhibitors
|
|
US6506876B1
(en)
|
1994-10-11 |
2003-01-14 |
G.D. Searle & Co. |
LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
|
|
DK0880363T3
(da)
|
1996-02-13 |
2003-01-20 |
Searle & Co |
Kombinationer der omfatter en cyclooxygenase-2 hæmmer samt en leukotrien A4 hydrolasehæmmer, som har immunsuppressive virkninger
|
|
US5952349A
(en)
*
|
1996-07-10 |
1999-09-14 |
Schering Corporation |
Muscarinic antagonists for treating memory loss
|
|
EP0927167A1
(en)
|
1996-08-14 |
1999-07-07 |
Warner-Lambert Company |
2-phenyl benzimidazole derivatives as mcp-1 antagonists
|
|
NO317155B1
(no)
|
1997-02-04 |
2004-08-30 |
Ono Pharmaceutical Co |
<omega>-cykloalkyl-prostagladin-E<N>2</N>-derivater
|
|
JP4044967B2
(ja)
|
1997-02-10 |
2008-02-06 |
小野薬品工業株式会社 |
１１，１５−ｏ−ジアルキルプロスタグランジンｅ誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤
|
|
DE19743435A1
(de)
*
|
1997-10-01 |
1999-04-08 |
Merck Patent Gmbh |
Benzamidinderivate
|
|
US6309561B1
(en)
|
1997-12-24 |
2001-10-30 |
3M Innovative Properties Company |
Liquid crystal compounds having a chiral fluorinated terminal portion
|
|
ES2216336T3
(es)
|
1997-12-25 |
2004-10-16 |
Ono Pharmaceutical Co., Ltd. |
Derivados omega-cicloalquilos de la prostaglandina e2.
|
|
US6380203B1
(en)
|
1998-01-14 |
2002-04-30 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
|
JP4087938B2
(ja)
|
1998-02-04 |
2008-05-21 |
高砂香料工業株式会社 |
ヒノキチオ−ル類の分岐サイクロデキストリン包接化合物からなる抗菌剤およびそれを含有する組成物
|
|
AU757290B2
(en)
|
1998-03-25 |
2003-02-13 |
Bristol-Myers Squibb Company |
Imidazolone anorectic agents: II. phenyl derivatives
|
|
GB9815880D0
(en)
|
1998-07-21 |
1998-09-16 |
Pfizer Ltd |
Heterocycles
|
|
US6235780B1
(en)
|
1998-07-21 |
2001-05-22 |
Ono Pharmaceutical Co., Ltd. |
ω-cycloalkyl-prostaglandin E1 derivatives
|
|
GB9919776D0
(en)
|
1998-08-31 |
1999-10-27 |
Zeneca Ltd |
Compoujnds
|
|
AR023659A1
(es)
|
1998-09-18 |
2002-09-04 |
Vertex Pharma |
Un compuesto inhibidor de p38, una composicion farmaceutica que lo comprende y el uso de dicha composicion en el tratamiento y prevencion de estados patologicos
|
|
US6699873B1
(en)
|
1999-08-04 |
2004-03-02 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
|
US6924313B1
(en)
|
1999-09-23 |
2005-08-02 |
Pfizer Inc. |
Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
|
|
US6800651B2
(en)
|
2000-02-03 |
2004-10-05 |
Eli Lilly And Company |
Potentiators of glutamate receptors
|
|
US6552023B2
(en)
|
2000-02-22 |
2003-04-22 |
Cv Therapeutics, Inc. |
Aralkyl substituted piperazine compounds
|
|
US6451798B2
(en)
|
2000-02-22 |
2002-09-17 |
Cv Therapeutics, Inc. |
Substituted alkyl piperazine derivatives
|
|
JP2001354657A
(ja)
|
2000-06-09 |
2001-12-25 |
Sds Biotech:Kk |
置換ピペラジン誘導体及び農園芸用殺菌剤
|
|
DE60114518T2
(de)
|
2000-07-06 |
2006-08-10 |
Fuji Photo Film Co. Ltd., Minamiashigara |
Flüssigkristallzusammensetzung, die Flüssigkristallmoleküle und Ausrichtungsmittel enthält
|
|
WO2002064211A1
(en)
|
2001-02-09 |
2002-08-22 |
Merck & Co., Inc. |
Thrombin inhibitors
|
|
JP4365094B2
(ja)
|
2001-03-02 |
2009-11-18 |
メルク フロスト カナダ リミテツド |
カテプシンシステインプロテアーゼ阻害薬
|
|
AUPR362001A0
(en)
|
2001-03-08 |
2001-04-05 |
Fujisawa Pharmaceutical Co., Ltd. |
New compound
|
|
FR2826011B1
(fr)
|
2001-06-14 |
2004-12-10 |
Oreal |
Nouveaux derives de la 7-oxo-dhea et utilisation cosmetique
|
|
SE0102616D0
(sv)
|
2001-07-25 |
2001-07-25 |
Astrazeneca Ab |
Novel compounds
|
|
US6869975B2
(en)
|
2001-09-14 |
2005-03-22 |
Tularik Inc. |
Linked biaryl compounds
|
|
AU2002363236A1
(en)
|
2001-10-30 |
2003-05-12 |
Millennium Pharmaceuticals, Inc. |
Compounds, pharmaceutical compositions and methods of use therefor
|
|
EP1556045B1
(en)
|
2002-10-04 |
2006-08-02 |
Ucb, S.A. |
4-aminopiperidine derivatives, processes for their preparation and their use as medicaments
|
|
AU2003290527A1
(en)
|
2002-10-17 |
2004-05-04 |
Decode Genetics Ehf. |
Susceptibility gene for myocardial infarction
|
|
US7851486B2
(en)
|
2002-10-17 |
2010-12-14 |
Decode Genetics Ehf. |
Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
|
|
AU2003300360A1
(en)
|
2002-12-20 |
2004-07-22 |
Migenix Corp. |
Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
|
|
EP1611902A4
(en)
|
2003-04-03 |
2006-04-12 |
Kyowa Hakko Kogyo Kk |
MEANS FOR THE PREVENTION AND / OR TREATMENT OF NEUROPATHIC PAIN
|
|
US7115642B2
(en)
|
2003-05-02 |
2006-10-03 |
Rigel Pharmaceuticals, Inc. |
Substituted diphenyl isoxazoles, pyrazoles and oxadiazoles useful for treating HCV infection
|
|
JP2005008581A
(ja)
|
2003-06-20 |
2005-01-13 |
Kissei Pharmaceut Co Ltd |
新規なピラゾロ［１，５−ａ］ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途
|
|
PT1660491E
(pt)
|
2003-07-28 |
2008-10-10 |
Janssen Pharmaceutica Nv |
Derivados de benzimidazole, benzotiazole e benzoxazole e a sua utilização como moduladores de lta4h
|
|
EP1670445A2
(en)
|
2003-09-17 |
2006-06-21 |
Decode Genetics EHF. |
Methods of preventing or treating recurrence of myocardial infarction
|
|
EP1669348A4
(en)
|
2003-09-30 |
2009-03-11 |
Eisai R&D Man Co Ltd |
NEW ANTIPILIC AGENT CONTAINING A HETEROCYCLIC COMPOUND
|
|
GB0326632D0
(en)
|
2003-11-14 |
2003-12-17 |
Jagotec Ag |
Dry powder formulations
|
|
DE10356579A1
(de)
|
2003-12-04 |
2005-07-07 |
Merck Patent Gmbh |
Aminderivate
|
|
SE0303480D0
(sv)
|
2003-12-19 |
2003-12-19 |
Biovitrum Ab |
Benzofuranes
|
|
EP1699847B1
(en)
|
2003-12-30 |
2011-04-13 |
3M Innovative Properties Company |
Method for the preparation of medicinal compositions
|
|
EP1713809B1
(en)
|
2004-02-04 |
2009-07-29 |
Neurosearch A/S |
Dimeric azacyclic compounds and their use
|
|
WO2006033795A2
(en)
|
2004-09-17 |
2006-03-30 |
Wyeth |
Substituted pyrazolo [1, 5-a] pyrimidines for inhibiting abnormal cell growth
|
|
MX2007011273A
(es)
|
2005-03-16 |
2007-11-08 |
Meda Pharma Gmbh & Co Kg |
La combinacion de anticolinergicos y antagonistas del receptor de leucotrieno para el tratamiento de enfermedades respiratorias.
|
|
EP1868605A2
(en)
|
2005-03-31 |
2007-12-26 |
Janssen Pharmaceutica, N.V. |
Phenyl and pyridyl lta4h modulators
|
|
US20090215742A1
(en)
|
2005-05-03 |
2009-08-27 |
Pfizer, Inc. |
Amide resorcinol compounds
|
|
KR20080011677A
(ko)
|
2005-05-31 |
2008-02-05 |
아스트라제네카 아베 |
신규 ｍｃｈｒ1 길항제 및 그의 ｍｃｈｒ1 매개된 상태 및장애의 치료를 위한 용도
|
|
GB0514018D0
(en)
|
2005-07-07 |
2005-08-17 |
Ionix Pharmaceuticals Ltd |
Chemical compounds
|
|
EA017618B1
(ru)
*
|
2005-09-21 |
2013-01-30 |
Декод Дженетикс Ехф |
Биарилзамещенные гетероциклические ингибиторы lta4h для лечения воспаления
|
|
CN1947717B
(zh)
|
2005-10-14 |
2012-09-26 |
卓敏 |
选择性抑制腺苷酸环化酶1的化合物在制备用于治疗神经性疼痛和炎性疼痛的药物中的应用
|
|
DE102005049954A1
(de)
|
2005-10-19 |
2007-05-31 |
Sanofi-Aventis Deutschland Gmbh |
Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
|
|
EP1976828B1
(en)
|
2005-12-29 |
2016-12-21 |
Celtaxsys, Inc. |
Diamine derivatives as inhibitors of leukotriene a4 hydrolase
|
|
TW200745025A
(en)
*
|
2005-12-29 |
2007-12-16 |
Schering Ag |
Amide inhibitors of leukotriene A4 hydrolase
|
|
AU2007215247B2
(en)
|
2006-02-10 |
2012-12-13 |
Transtech Pharma, Llc |
Benzazole derivatives, compositions, and methods of use as Aurora kinase inhibitors
|
|
US20100029619A1
(en)
|
2006-08-04 |
2010-02-04 |
Takeda Pharmaceutical Company Limted |
Fused heterocyclic compound
|
|
DE602007005671D1
(de)
*
|
2006-10-19 |
2010-05-12 |
Hoffmann La Roche |
Aminomethyl-2-imidazole mit affinität zu mit dem trace-amin assoziierten rezeptoren
|
|
JP5219465B2
(ja)
*
|
2006-11-10 |
2013-06-26 |
大塚製薬株式会社 |
医薬
|
|
LT2121636T
(lt)
|
2006-12-14 |
2017-05-10 |
Janssen Pharmaceutica N.V. |
Piperazinilo ir diazepanilo benzamido darinių gamybos būdas
|
|
FR2911139A1
(fr)
|
2007-01-05 |
2008-07-11 |
Sanofi Aventis Sa |
Nouveaux derives de phenyl-(4-phenyl-pyrimidin-2-yl)amines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
FR2911138B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
FR2911140B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de 2-anilino 4-heteroaryle pyrimides, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
CA2691662A1
(en)
|
2007-07-02 |
2009-01-08 |
F. Hoffmann-La Roche Ag |
Imidazole derivatives as ccr2 receptor antagonists
|
|
KR101167773B1
(ko)
|
2007-08-03 |
2012-07-24 |
에프. 호프만-라 로슈 아게 |
Ｔａａｒ１ 리간드로서의 피리딘카복스아마이드 및 벤즈아마이드 유도체
|
|
AR068498A1
(es)
|
2007-09-27 |
2009-11-18 |
Merck & Co Inc |
Compuestos de oxadiazol para inhibicion de biosintesis de leucotrienos
|
|
KR20100098683A
(ko)
|
2007-12-12 |
2010-09-08 |
아스트라제네카 아베 |
펩티딜 니트릴, 및 디펩티딜 펩티다제 ｉ 억제제로서의 그의 용도
|
|
BRPI0908529A2
(pt)
|
2008-02-26 |
2015-09-29 |
Novartis Ag |
composto orgânicos
|
|
FR2928070A1
(fr)
|
2008-02-27 |
2009-09-04 |
Sumitomo Chemical Co |
Composition agricole, utilisation d'un compose pour sa production et procede pour matriser ou prevenir les maladies des plantes.
|
|
US20100029657A1
(en)
|
2008-02-29 |
2010-02-04 |
Wyeth |
Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof
|
|
CA2721099C
(en)
|
2008-04-11 |
2017-04-25 |
Janssen Pharmaceutica Nv |
Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene a4 hydrolase
|
|
EP2110374A1
(en)
|
2008-04-18 |
2009-10-21 |
Merck Sante |
Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators
|
|
WO2010011912A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Trpv4 antagonists
|
|
DK2222272T3
(da)
|
2008-08-07 |
2013-02-11 |
Pulmagen Therapeutics Inflammation Ltd |
Behandling af luftvejssygdom
|
|
BRPI1010511A2
(pt)
|
2009-04-09 |
2019-04-09 |
Alkermes Pharma Ireland Limited |
composição, e, métodos para tratar um paciente que sofre de esquizofrenia, e para reduzir o risco de comportamento suicida recorrente em um paciente com esquizofrenia ou desordem esquizoafetiva
|
|
CN102030700B
(zh)
|
2009-09-30 |
2016-06-01 |
中国医学科学院药物研究所 |
苯甲酰胺基羧酸类化合物及其制法和药物用途
|
|
JP5781527B2
(ja)
*
|
2009-10-30 |
2015-09-24 |
ヤンセン ファーマシューティカ エヌ．ベー． |
４−置換−２−フェノキシ−フェニルアミンデルオピオイド受容体調節因子
|
|
EP2509982A1
(en)
|
2009-12-07 |
2012-10-17 |
Targacept, Inc. |
3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetylcholine receptor ligands
|
|
JP2013047189A
(ja)
|
2009-12-25 |
2013-03-07 |
Kyorin Pharmaceutical Co Ltd |
新規パラバン酸誘導体及びそれらを有効成分とする医薬
|
|
KR101764952B1
(ko)
*
|
2010-07-29 |
2017-08-03 |
리겔 파마슈티칼스, 인크. |
Ａｍｐｋ-활성화 헤테로시클릭 화합물 및 그의 사용 방법
|
|
WO2012067822A1
(en)
|
2010-11-16 |
2012-05-24 |
Abbott Laboratories |
Pyrazolo [1, 5 -a] pyrimidin potassium channel modulators
|
|
EA023876B1
(ru)
|
2011-03-14 |
2016-07-29 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Бензодиоксановые ингибиторы продуцирования лейкотриена
|
|
PH12013501882A1
(en)
|
2011-03-15 |
2013-10-14 |
Rib X Pharmaceuticals Inc |
Antimicrobial agents
|
|
SG194135A1
(en)
|
2011-04-12 |
2013-11-29 |
Matrix Inc Moerae |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
|
WO2012162407A1
(en)
|
2011-05-23 |
2012-11-29 |
Janssen Pharmaceutica Nv |
Picolinamido - propanoic acid derivatives useful as glucagon receptor antagonists
|
|
CN103159742B
(zh)
*
|
2011-12-16 |
2015-08-12 |
北京韩美药品有限公司 |
5-氯嘧啶类化合物及其作为egfr酪氨酸激酶抑制剂的应用
|
|
US9006235B2
(en)
|
2012-03-06 |
2015-04-14 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
EP2827849A4
(en)
|
2012-03-23 |
2015-11-18 |
Univ Leland Stanford Junior |
TREATMENT OF PULMONARY HYPERTONIA WITH LEUKOTRIENHEMMERN
|
|
ES2864862T3
(es)
|
2013-03-12 |
2021-10-14 |
Celltaxis Llc |
Métodos de inhibición de la leucotrieno A4 hidrolasa
|
|
MX2015011678A
(es)
*
|
2013-03-14 |
2016-07-08 |
Celtaxsys Inc |
Inhibidores de leucotrieno a4 hidrolasa.
|
|
MX2015011677A
(es)
|
2013-03-14 |
2016-07-08 |
Celtaxsys Inc |
Inhibidores de leucotrieno a4 hidrolasa.
|
|
CA2906086A1
(en)
*
|
2013-03-14 |
2014-09-25 |
Celtaxsys, Inc. |
Inhibitors of leukotriene a4 hydrolase
|